Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-26

Clinical Trial Update: Intraoperative Liposomal Bupivacaine vs. Bupivacaine for Total Hip Replacement Pain Management [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intraoperative liposomal bupivacaine (Exparel) with standard bupivacaine for postoperative pain control after total hip replacement; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: American Hip Institute | Conditions: Pain, Postoperative | Phase 2 | Status: COMPLETED | Results posted: 2018-07-26